Evidence map›Paper›PMID 31435355›Full record

ArticleJournal of Taibah University Medical Sciences2018

Therapeutic effects of balanitoside in streptozotocin-induced diabetic rats.

Wusa Makena, Wilson O Hamman, Adebayo A Buraimoh, Nathan I Dibal, Sunday G Obaje

Open access · goldAbstract read
In one paragraph

Article in Journal of Taibah University Medical Sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Wusa MakenaDepartment of Human Anatomy, Faculty of Medical Sciences, Ahmadu Bello University of Zaria, Kaduna State, Nigeria.
Wilson O HammanDepartment of Human Anatomy, Faculty of Medical Sciences, Ahmadu Bello University of Zaria, Kaduna State, Nigeria.
Adebayo A BuraimohDepartment of Human Anatomy, Faculty of Basic Medical Sciences, Kaduna State University, Kaduna, Nigeria.
Nathan I DibalDepartment of Human Anatomy, College of Medical Sciences, University of Maiduguri, Borno State, Nigeria.
Sunday G ObajeDepartment of Human Anatomy, Faculty of Basic Medical Sciences, Federal University Ndufu Alike Ikwo, Ebonyi State, Nigeria.
Ahmadu Bello University · NGFederal Medical Centre · NGKaduna State University · NGUniversity of Maiduguri · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective of this study was to evaluate the therapeutic effects of balanitoside in diabetic rats.

methodsTwenty-five rats were divided into five groups. Rats in groups 2 to 5 were treated with streptozotocin to induce hyperglycemia. In addition, rats in groups 1 and 2 received 1 mL of distilled water, whereas those in groups 3, 4, and 5 received 10 and 20 mg/kg balanitoside and 6 U/kg insulin, respectively, for 14 days. All rats were sacrificed on day 15, blood samples were collected, and serum levels of alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were measured. The liver was processed for examination under a light microscope.

resultsThe results showed a significant decrease in liver protein concentrations in diabetic control rats, compared to those in the normal control rats and rats treated with 10 mg/kg balanitoside (

conclusionThe findings of this study suggest the therapeutic effects of balanitoside in the liver of diabetic rats.

Indexed as

BalanitosideDiabetes mellitusHyperglycemiaLiverProtein concentration

Identifiers

PMID31435355
PMCPMC6695012
OpenAlexW2793292533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.